£5m single-case MRSA compensation is "NHS wake-up call"
This article was originally published in Clinica
A UK NHS patient is to receive record-breaking compensation of £5m ($9.8m) for damages in relation to contracting a strain of methicillin-resistant Staphylococcus aureus (MRSA). The infection was contracted following an operation at London's Chelsea and Westminster hospital, in 2004. The amount, which far exceeds normal compensation levels, is being awarded (in principle, Clinica understands) to a television celebrity for the seriousness and career-damaging sequelae of the infection. The payout is comparable to the total MRSA compensation awarded during 2002-06. Nevertheless, it was welcomed by the Patients Association as a "wake-up call for the NHS" to tighten infection controls. Almost 6,400 cases of MRSA were recorded in England in 2007.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.